A consensus protocol for functional connectivity analysis in the rat brain
- PMID: 36973511
- PMCID: PMC10493189
- DOI: 10.1038/s41593-023-01286-8
A consensus protocol for functional connectivity analysis in the rat brain
Erratum in
-
Author Correction: A consensus protocol for functional connectivity analysis in the rat brain.Nat Neurosci. 2023 Jun;26(6):1127-1128. doi: 10.1038/s41593-023-01328-1. Nat Neurosci. 2023. PMID: 37072562 No abstract available.
Abstract
Task-free functional connectivity in animal models provides an experimental framework to examine connectivity phenomena under controlled conditions and allows for comparisons with data modalities collected under invasive or terminal procedures. Currently, animal acquisitions are performed with varying protocols and analyses that hamper result comparison and integration. Here we introduce StandardRat, a consensus rat functional magnetic resonance imaging acquisition protocol tested across 20 centers. To develop this protocol with optimized acquisition and processing parameters, we initially aggregated 65 functional imaging datasets acquired from rats across 46 centers. We developed a reproducible pipeline for analyzing rat data acquired with diverse protocols and determined experimental and processing parameters associated with the robust detection of functional connectivity across centers. We show that the standardized protocol enhances biologically plausible functional connectivity patterns relative to previous acquisitions. The protocol and processing pipeline described here is openly shared with the neuroimaging community to promote interoperability and cooperation toward tackling the most important challenges in neuroscience.
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests
A.S. is an employee of Bruker, the manufacturer of preclinical MRI systems used for the acquisition of most of the datasets in this collection. E.L.B. is a consultant for Bruker. B.V. is an employee of Theranexus. S.Z., A.D. and N.B. are employees of Novartis Pharma AG. T.N. is founder and CEO of MRI.TOOLS GmbH. The other authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Grants and funding
- R03 DA042971/DA/NIDA NIH HHS/United States
- S10 OD026796/OD/NIH HHS/United States
- P30 NS052519/NS/NINDS NIH HHS/United States
- R21 MH116473/MH/NIMH NIH HHS/United States
- R01 MH067528/MH/NIMH NIH HHS/United States
- R01 NS078095/NS/NINDS NIH HHS/United States
- T32 AA007573/AA/NIAAA NIH HHS/United States
- T32 GM007205/GM/NIGMS NIH HHS/United States
- R01 MH098003/MH/NIMH NIH HHS/United States
- R37 MH085953/MH/NIMH NIH HHS/United States
- T32 EB025816/EB/NIBIB NIH HHS/United States
- K01 EB023983/EB/NIBIB NIH HHS/United States
- K25 DA047458/DA/NIDA NIH HHS/United States
- RF1 NS113278/NS/NINDS NIH HHS/United States
- I01 CX000642/CX/CSRD VA/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- T32 GM136651/GM/NIGMS NIH HHS/United States
- S10 MH124733/MH/NIMH NIH HHS/United States
- R21 AG065819/AG/NIA NIH HHS/United States
- RF1 MH117053/MH/NIMH NIH HHS/United States
- R01 MH111416/MH/NIMH NIH HHS/United States
- S10 RR025671/RR/NCRR NIH HHS/United States
- R21 NS121642/NS/NINDS NIH HHS/United States
- R01 NS122904/NS/NINDS NIH HHS/United States
- R01 MH126518/MH/NIMH NIH HHS/United States
- S10 OD028616/OD/NIH HHS/United States
- S10 MH124745/MH/NIMH NIH HHS/United States
- R01 NS085200/NS/NINDS NIH HHS/United States
- F31 MH115656/MH/NIMH NIH HHS/United States
- RF1 MH114224/MH/NIMH NIH HHS/United States
- 212219/Z/18/Z/WT_/Wellcome Trust/United Kingdom
- R01 EB029857/EB/NIBIB NIH HHS/United States
LinkOut - more resources
Full Text Sources
